Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression.
This study examined the risk factors for genital human papillomavirus (HPV) infection, including HIV-related immunosuppression as well as demographic and behavioral factors.
Subjects were 207 women with known HIV serologic status, the majority of whom were intravenous drug users recruited from a methadone treatment program in the Bronx, New York.
A structured questionnaire interview, cervico-vaginal lavage, and CD4 cell measurements were obtained.
HPV genomes in the cervico-vaginal cells were detected by Southern-blot hybridization: HPV prevalence was 23% among HIV seronegatives, 45% among HIV seropositives with CD4 percent >20 and 61% among HIV seropositives with CD4 percent <=20.
Mots-clés Pascal : SIDA, Virose, Infection, Séropositivité, Immunodépression, Appareil génital femelle, Papillomavirus humain, Papillomavirus, Papovaviridae, Virus, Facteur risque, Epidémiologie, Etats Unis, Amérique du Nord, Amérique, Homme, Immunodéficit, Immunopathologie, Appareil génital femelle pathologie
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Seropositivity, Immunosuppression, Female genital system, Human papillomavirus, Papillomavirus, Papovaviridae, Virus, Risk factor, Epidemiology, United States, North America, America, Human, Immune deficiency, Immunopathology, Female genital diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0318839
Code Inist : 002B05C02E. Création : 199406.